1. Home
  2. BBIO vs NXT Comparison

BBIO vs NXT Comparison

Compare BBIO & NXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • NXT
  • Stock Information
  • Founded
  • BBIO 2015
  • NXT 2013
  • Country
  • BBIO United States
  • NXT United States
  • Employees
  • BBIO N/A
  • NXT N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • NXT Semiconductors
  • Sector
  • BBIO Health Care
  • NXT Technology
  • Exchange
  • BBIO Nasdaq
  • NXT Nasdaq
  • Market Cap
  • BBIO 8.8B
  • NXT 8.8B
  • IPO Year
  • BBIO 2019
  • NXT 2023
  • Fundamental
  • Price
  • BBIO $47.27
  • NXT $58.26
  • Analyst Decision
  • BBIO Strong Buy
  • NXT Buy
  • Analyst Count
  • BBIO 16
  • NXT 20
  • Target Price
  • BBIO $61.50
  • NXT $62.70
  • AVG Volume (30 Days)
  • BBIO 2.2M
  • NXT 2.5M
  • Earning Date
  • BBIO 08-05-2025
  • NXT 07-29-2025
  • Dividend Yield
  • BBIO N/A
  • NXT N/A
  • EPS Growth
  • BBIO N/A
  • NXT N/A
  • EPS
  • BBIO N/A
  • NXT 3.67
  • Revenue
  • BBIO $127,415,000.00
  • NXT $3,103,529,000.00
  • Revenue This Year
  • BBIO $106.33
  • NXT $13.65
  • Revenue Next Year
  • BBIO $54.30
  • NXT $10.67
  • P/E Ratio
  • BBIO N/A
  • NXT $15.89
  • Revenue Growth
  • BBIO N/A
  • NXT 13.26
  • 52 Week Low
  • BBIO $21.72
  • NXT $30.93
  • 52 Week High
  • BBIO $48.68
  • NXT $67.87
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 64.57
  • NXT 42.58
  • Support Level
  • BBIO $45.11
  • NXT $59.77
  • Resistance Level
  • BBIO $47.11
  • NXT $65.66
  • Average True Range (ATR)
  • BBIO 1.40
  • NXT 2.47
  • MACD
  • BBIO -0.26
  • NXT -0.55
  • Stochastic Oscillator
  • BBIO 60.53
  • NXT 13.40

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About NXT Nextracker Inc.

Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

Share on Social Networks: